IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act

Author(s):  Pore R David

Issue:  Nov/Dec 2012 - Volume 16, Number 6
View All Articles in Issue

Abstract:  This article provides a summary of the Drug Enforcement Agency’s current interpretation of the Controlled Substances Act as it relates to the “constructive transfer” of certain controlled substances from pharmacist to physician for office administration. The article discusses compliance with the Controlled Substances Act in this context and related legislative and legal activities of individual pharmacists and of the International Academy of Compounding Pharmacists and other groups.

Related Keywords: R. David Pore, MA, JD, U.S. Drug Enforcement Agency, DEA, constructive transfer, Controlled Substances Act, DEA Form 222, compounded sterile preparations

Related Categories: LEGAL, PAIN MANAGEMENT, PROFESSIONAL ISSUES

Printer-Friendly Version




Download in electronic PDF format for $35

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act Pore R David Nov/Dec 2012 446-450 Buy
The International Academy of Compounding Pharmacists Stepping Up Efforts to Remedy Problems Caused by the U.S. Drug Enforcement Administration's "Constructive Transfer" Policy Miller David G Mar/Apr 2012 94-96 View Sample
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G Jul/Aug 2015 303-305 Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr Jul/Aug 2016 351 View Sample
Standing Together Fixing the Drug Quality and Security Act Miller David G Mar/Apr 2015 104-106 Buy
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr Nov/Dec 2015 487-488 Buy
U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013 Miller David G Jan/Feb 2014 35-36 Buy
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Williams LaVonn A Nov/Dec 2011 526-527 Buy
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Miller David G Sep/Oct 2012 382-384 Buy
Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications Gilbert John A Sep/Oct 2009 400-403 Buy